On July 6, 2010
Merck’s Silence Over Parkinson’s Drug Shortage Is Unfair and Unacceptable
Merck (MRK)’s mysterious silence over the shortage of its Parkinson’s Disease drug Sinement has provoked some high-profile enemies. A Scottish member of parliament and a U.K. Parkinson’s charity have both turned on the company, demanding an explanation and an end
…
0 Comments